Deep Genomics is a startup based in Toronto that uses artificial intelligence (AI) and machine learning to develop new therapies for genetic diseases. The company was founded in 2015 by Brendan Frey, a leading researcher in the field of genomic medicine.
Deep Genomics uses AI to analyze large amounts of genomic data and identify patterns that can help scientists understand how genetic variations affect human health. The company’s goal is to use this knowledge to develop therapies that can target specific genetic mutations and restore normal function to cells and tissues.
One of the main areas of focus for Deep Genomics is developing therapies for rare genetic diseases, which often have few or no treatment options. The company is also working on developing personalized therapies for cancer, which could be tailored to the specific genetic makeup of an individual patient.
Overall, Deep Genomics is at the forefront of using AI and machine learning to advance the field of genomic medicine and improve the lives of people with genetic diseases.
